Extendicare (TSE:EXE) reported sharply higher second-quarter revenue and adjusted EBITDA as its recently completed acquisitions contributed for a full quarter, while management said it remains focused on integrating CBI Home Health and advancing its Ontario long-term-care redevelopment program. Rev

Extendicare Inc (EXETF) reports a 71.7% surge in adjusted EBITDA, driven by the CBI acquisition and robust organic growth, while navigating margin pressures and integration milestones.

Extendicare Inc (EXETF) recently announced a total dividend of $0.03 per share, with the ex-dividend date set for 2026-07-31. This upcoming payment includes a $0.03 per share cash dividend, payable on 2026-08-17. As investors look forward to this payment, the spotlight also shines on the company's dividend history, yield, and growth rates.

Extendicare (TSX:EXE) has caught investor attention after a strong run, with the share price sitting at CA$30.19 and total return figures over the past year and past 3 months reinforcing interest in the senior care operator. See our latest analysis for Extendicare. The recent 7 day share price return of 6.53% and 30 day share price return of 16.83% build on a 43.22% year to date share price gain. The 1 year total shareholder return of 125.14% highlights how strong the recent momentum has...

Extendicare (TSX:EXE) has completed a CA$450 million senior unsecured note offering. The company has used the proceeds to refinance existing debt and restructure its credit facilities. This transaction changes Extendicare's capital structure and credit profile. Extendicare, trading at CA$29.59, has seen very strong share price performance, with the stock up 40.4% year to date and 130.5% over the past year. Returns of 9.7% over the past month and 2.7% over the past week suggest investors...

CIBC Capital Markets recently reiterated its outperformer rating on Extendicare after the company closed a C$570 million acquisition of home health care operator CBI Health, reported Q4 results above expectations, increased its dividend, and received a BBB credit rating from DBRS. At the same time, labour tensions escalated as CUPE, representing over 30,000 long-term care and retirement home workers, prepared for a “summer of action” in response to stalled negotiations with Extendicare,...

Extendicare (TSX:EXE) has been in focus after closing a $570 million acquisition of CBI Health, posting above-consensus Q4 results, raising its dividend, and receiving a BBB credit rating from DBRS. See our latest analysis for Extendicare. At a share price of CA$27.76, the stock has logged a 31.69% 90 day share price return and a very large 3 year total shareholder return. This suggests momentum has been building as investors react to the CBI Health acquisition, a higher dividend, and the...

CIBC Capital Markets on Wednesday reiterated its outperformer rating on the shares of Extendicare (E

Recent performance puts Extendicare on investor radar Extendicare (TSX:EXE) has drawn fresh attention after a strong year, with a 1 year total return above 100% and revenue of CA$1.66b, paired with net income of CA$96.66m. See our latest analysis for Extendicare. The recent 10.1% 1 day share price return and 14.6% 30 day share price return, on top of a 121.1% 1 year total shareholder return and very large 5 year total shareholder return above 4x, point to strong momentum building around...